Safety and effectiveness of gemcitabine for the treatment of classic Kaposi's sarcoma without visceral involvement.

Giuseppe BadalamentiAntonio RussoLaura AlgeriAnnalisa BonaseraAlessandra DiminoRaimondo ScaliaAlessandra CucinellaGiorgio MadoniaFederica Li PomiAntonio GalvanoValerio GristinaFrancesca ToiaAdriana CordovaViviana BazanAntonio Russo

Published in: Therapeutic advances in medical oncology (2022)

Our study showed that gemcitabine is effective and well tolerated, acts rapidly on cutaneous lesions, and allows substantial symptom palliation, without dose-limiting toxicity. Gemcitabine represents a safe and effective option for the treatment of CKS.

Keyphrases

randomized controlled trial
systematic review
locally advanced
squamous cell carcinoma
type diabetes
oxidative stress
metabolic syndrome
combination therapy
radiation therapy
adipose tissue